Background Effective disease surveillance, including that for COVID-19, is compromised
without a standardised method for categorising the immunosuppressed as a clinical risk …

Abstract Purpose Mixed cryoglobulinemia syndrome (MCs) is a rare immunoproliferative
systemic disorder with cutaneous and multiple organ involvement. Our multicenter survey …

Objective To identify risk factors for SARS-CoV-2 infection and for severe/critical COVID-19,
and to assess the humoral response after COVID-19 in these patients. Methods Nationwide …

Objectives To investigate the outcomes of COVID‐19‐related hospitalizations among
patients with autoimmune rheumatic diseases (ARDs) in the United States in 2020. The …

Objectives The impact of rheumatic diseases, long‐term medication, and vaccination on
COVID‐19 severity remain insufficiently understood, hindering effective patient …

Objective The COVID-19 pandemic, along with the associated restrictions and changes, has
had a far-reaching impact on the mental health and well-being of people around the world …

Background A general comprehension of coronavirus disease-2019 (COVID-19)
characteristics in patients with autoimmune and/or rheumatic diseases (ARDs) is required …

Objective There is dearth of data regarding the outcomes of coronavirus disease 2019
(COVID-19) among rheumatic and musculoskeletal disease (RMD) patients from Southeast …

Introduction Data concerning SARS-CoV-2 in patients affected by SLE are contradicting. The
aim of this study was to investigate disease-related differences in COVID-19 prognosis of …

Rheumatic disease patients are at greater risk of infection due to their disease,
comorbidities, and immunosuppressive therapy. COVID-19 outcomes in this patient setting …